Building on our core separation technologies using hollow-fiber membranes and adsorbent materials, our therapeutic and bioprocess filtration products have become the de facto standards in blood purification and pharmaceutical safety enhancement technology.

We are proud to have contributed to higher standards and greater reliability in products and technology through our uncompromising pursuit of product quality to ensure safety in biopharmaceutical and plasma derivative production processes as well as hemodialysis and therapeutic apheresis blood purification treatments.

Japan has an international reputation for manufacturing skill and precision. The Asahi Kasei Group is squarely in this tradition. Leveraging the synergy of the group’s wide array of technology centered on chemicals and materials, together with its stable business foundation, we have established a proven track record of providing safe and reliable technologies, products and services to numerous medical facilities and pharmaceutical manufacturers.

Sophisticated manufacturing technology, rigorous quality assurance and thoroughgoing support are hallmarks of the Asahi Kasei Group. Compromise is unacceptable and “good enough” is out of the question. In the healthcare field, where human life is in the balance, standards of quality must be set higher still. Growth in global markets may call for national or regional optimization that takes social, economic and cultural factors into account, but we will always insist on maintaining our commitment to quality while developing production technologies that give us the competitive edge in cost and speed.